期刊文献+

EGCG通过降低Notch1和Jagged1表达抑制鼻咽癌干细胞SP18的增殖 被引量:6

EGCG Decreased the Expression of Notch1 and Jagged1 Proteins and Inhibited the Proliferation of Nasopharyngeal Cancer Stem Cell SP18
暂未订购
导出
摘要 目的探讨表没食子儿茶素没食子酸酯(EGCG)抑制鼻咽癌干细胞SP18增殖的机制。方法采用MTT法检测EGCG抑制SP18细胞增殖的IC50;选用细胞生长曲线、平皿克隆形成实验和软琼脂集落形成实验观察EGCG对鼻咽癌干细胞SP18增殖的影响;采用Western blot检测Notch1和Jagged1蛋白表达。结果 EGCG抑制SP18细胞增殖的IC50值为149.02 mg/L;EGCG呈浓度和时间依赖性抑制SP18细胞的增殖(n=3,P<0.05);EGCG呈浓度依赖性抑制Notch1和Jagged1蛋白的表达。结论 EGCG能有效抑制鼻咽癌干细胞SP18的增殖,其可能通过降低Notch1和Jagged1蛋白的表达而发挥作用。 Objective To analyze the mechanism of Epigallocatechin-3-gallate (EGCG) inhibiting the proliferation of nasopbaryngeal cancer stem cell SP18. Methods 50% inhibiting concentration ( ICs0 ) of which EGCG inhibited the proliferation of nasopharyngeal cancer stem cell SP18 was detected by MTT method. The proliferation of SP18 cells affected by EGCG was analyzed by the cellular growth curve, colony formation and soft agar formation. Then the expression of Notehl and Jaggedl protein were respectively detected by Western blot in SP18 cells treated by EGCG. Results IC50, of which EGCG inbibted the proliferation of SP18 cells ,was 149.02 mg/L. The proliferation of SP18 cells was inhibited with EGCG concentration increasing and treatment time extending ( n = 3 ,P 〈 0.05 ). The expression of Notchl and Jaggedl proteins in SP18 cells was obviously deceased with EGCG concentration increased. Conclusion EGCG can inhibit the proliferation of nasopharyngeal cancer stem cell SP18, which probably decreased the expression of Notchl and Jaggedl proteins to a- chieve the role.
出处 《中南医学科学杂志》 CAS 2013年第5期440-444,共5页 Medical Science Journal of Central South China
基金 湖南省自然科学省市联合基金(12JJ9033) 湖南省自然科学基金(12JJ3102 13JJ3079) 湖南省高校创新平台开放基金(12K094 10K052) 湖南省研究生科研创新项目(CX2010B380) 湖南省教育厅科研项目(11C1112 12C0340) 衡阳市科技局科研项目(2011kj52 2011kj53)
关键词 EGCG 鼻咽癌干细胞SP18 细胞增殖 NOTCH1蛋白 Jagged1蛋白 Epigallocatechin-3-gallate nasopharyngeal cancer stem cell SP18 cellular proliferation Notchlprotein Jaggedl protein
  • 相关文献

参考文献19

  • 1Wang L, Chen F, Zhang Z, et aI. Cancer stem cells in the mechanism of metal carcinogenesis [ J ]. J Environ Pathol Toxicol Onco1,2012,31 ( 3 ) :245-263.
  • 2Cheng L, Alexander R, Zhang S, et al. The clinicaI and therapeutic implications of cancer stem cell biology [ J]. Expert Rev Antieancer Ther,2011,11 ( 7 ) : 1131 -I 143.
  • 3Wang J, Guo LP, Chen LZ, et ah Identification of cancer stem cell-like side population ceils in human nasopharyn-geal carcinoma cell line [ J ]. Cancer Res, 2007,67 ( 8 ) : 3716-3724.
  • 4Braicu C, Gherman CD, Irimie A, et al. Epigallocatechin- 3-Gallate (EGCG) inhibits cell proliferation and migra- tory behaviour of triple negative breast cancer ceils [ J ]. J Nanosci Nanotechno1,2013,13 ( 1 ) :632-637.
  • 5Liu LC,Tsao TC, Hsu SR, et al. EGCG inhibits transfor- ming growth factor-13-mediated epithelial-to-mesencbymal transition via the inhibition of Smad2 and Erkl/2 signa- ling pathways in nonsmall cell lung cancer cells[ J]. J Ag- ric Food Chem,2012,60(39):9863-9873.
  • 6Vrzina A, Chokor R, Annabi B. EGCG targeting efficacy of NF-KB downstream gene products is dictated by the monocytic/macrophagic differentiation status of promyelo- cytic leukemia cells [ J ]. Cancer Immunol Immunother, 2012,61 (12) :2321-2331.
  • 7Lee YH, Kwak J, Choi HK, et al. EGCG suppresses pros- tate cancer cell growth modulating acetylation of androgen receptor by anti-histone acetyltransferasc activity [ J ]. Int J Mol Med,2012,30( l ) :69-74.
  • 8Wang J, Sullenger BA, Rich JN. Notch signaling in cancer stem cells [J] Adv Exp Med Biol, 2012, 727 (1):.174-185.
  • 9Milla LA, Gonzdlez-Ramirez CN, Palma V. Sonic Hedge- hog in cancer stem eells:a novel link with autophagy[ J]. Biol Res ,2012,45 (3) :223-230.
  • 10Wang Y, Zhe H, Ding Z, et al. Cancer stem cell marker Bmi-1 expression is associated with basaMike phenotype and poor survival in breast cancer [ J ]. World J Surg, 2012,36(5 ) : 1189-1194.

同被引文献140

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部